Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06703567 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

IMproving PAtient UndeRstanding of GEP TEst Results: Phase 4

Study acronym: IMPARTER
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 10, 2024 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study Identification, Study Status, Oversight, Arms and Interventions, Outcome Measuresv2
  2. Study First Submitted
The primary aim of the study is to determine if provision of a patient information film about Oncotype DX improves patients' knowledge and understanding about Gene Expression Profiling (GEP) test and risk of recurrence results in early breast cancer (EBC) patients, identified by their clinical teams as potentially benefiting from having their tumor samples sent for GEP analysis.
Trial Details
NCT Number NCT06703567
Lead Sponsor European Institute of Oncology
Conditions
(from sponsor)		 Breast Cancer
Related terms Breast Neoplasms
Enrollment 82 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov